您的位置: 首页 > 农业专利 > 详情页

AMP derivatives for the treatment of heart disease
专利权人:
University of Connecticut;The United States Of America, As Represented By The Secretary, Department of Health and Human Services
发明人:
LIANG, Bruce,JACOBSON, Kenneth A.,JOSHI, Bhalchandra V.,KUMAR, Thatikonda Santosh
申请号:
DK11713395
公开号:
DK2539352T3
申请日:
2011.02.22
申请国别(地区):
DK
年份:
2018
代理人:
摘要:
Phosphonate and phosphinate N-methanocarba derivatives of AMP including their prodrug analogs are described. MRS2339, a 2-chloro-AMP derivative containing a (N)-methanocarba (bicyclo[3.1.0]hexane) ring system in place of ribose, activates P2X receptors, ligand-gated ion channels. Phosphonate analogs of MRS2339 were synthesized using Michaelis-Arbuzov and Wittig reactions, based on the expectation of increased half-life in vivo due to the stability of the C—P bond. When administered to calsequestrin-overexpressing mice (a genetic model of heart failure) via a mini-osmotic pump (Alzet), some analogs significantly increased intact heart contractile function in vivo, as assessed by echocardiography-derived fractional shortening (FS) as compared to vehicle-infused mice. The range of carbocyclic nucleotide analogs for treatment of heart failure has been expanded.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充